Infection Prevention and Control
HHS purchased $26 million worth of intravenous TPOXX (tecovirimat) to treat monkeypox, which the manufacturer expects to deliver next year.
President Biden named Federal Emergency Management Agency Region 9 Administrator Robert Fenton to coordinate the administration’s monkeypox response.
Inpatient and outpatient prospective payment system hospitals, inpatient psychiatric facilities and PPS-exempt cancer hospitals have until Aug. 30 to preview their data for the October update to Care Compare.
World Health Organization Director-General Tedros Adhanom Ghebreyesus Saturday declared monkeypox a public health emergency of international concern and recommended governments take certain steps to strengthen and coordinate the global response to the outbreak.
The CDC endorsed the two-dose Novavax COVID-19 vaccine as a COVID-19 vaccine primary series for emergency use in adults, as recommended by its advisory committee.
The CDC's Advisory Committee on Immunization Practices today recommended the two-dose Novavax COVID-19 vaccine as a COVID-19 vaccine primary series for emergency use in adults.
A third and fourth dose of the Pfizer or Moderna COVID-19 vaccine provided additional protection to eligible adults, the CDC reported Friday.
The Department of Health and Human Services today announced plans to make available an additional 144,000 doses of the JYNNEOS vaccine used to combat monkeypox. The doses will begin shipping from the Strategic National Stockpile on July 11; they will be available to states and jurisdictions.…
The FDA authorized state-licensed pharmacists to prescribe Paxlovid to patients as a treatment for those at high risk of severe COVID-19.
HHS ordered an additional 2.5 million doses of an FDA-licensed vaccine for prevention of smallpox and monkeypox, for use in responding to current or future monkeypox outbreaks and as part of the nation’s smallpox preparedness.